Continuous bioprocessing: A ‘life changing’ method, says NIBRT

By Flora Southey

- Last updated on GMT

NIBRT is embracing continuous bioprocessing says training director John Milne, who told us the method helps improve plant flexibility and could reduce manufacturing costs.

On a site visit last month at Ireland’s National Institute for Bioprocessing Research and Technology (NIBRT) in Dublin, Milne told Biopharma-Reporter the continuous method – as opposed to batch – is attracting increased interest in the biologics space.

“In the small molecule industry for example, people have been applying these strategies.

“Biologics has taken a longer time to be convinced,” ​said Milne, but added he has observed a lot of activity in continuous manufacturing, and will “definitely see more.”

“It is going to change our lives in a very positive way going forward.”

Speaking to delegates at the Biopharma Ambition Conference – also in Dublin – CEO Dominic Carolan said the bioprocessing method has not been taken onboard by all firms.

“Some companies are certainly looking at it closely, some companies have decided perhaps it’s not for them at this point.

“The technologies need to be developed, because this has huge potential of course for reducing cost in the future,” ​he added.

Continuous bioprocessing training is gaining traction, as demonstrated by Pall Life Sciences announcement​ last year to equip a Swiss training facility in order to theoretical and practical training in the continuous method to biomanufacturers.

Related news

Show more

Related products

show more

Process optimization for mAb commercial manufacturing

Process optimization for mAb commercial manufacturing

Content provided by Catalent | 01-Jun-2023 | Product Presentation

Process characterization and validation is an important step in the product development journey and late-phase development, and it is required before transferring...

Riding the mRNA Highway

Riding the mRNA Highway

Content provided by Thermo Fisher Scientific - Biosciences | 15-May-2023 | White Paper

Learn more about process development and manufacturing in the mRNA space to enable successful scale-ups of mRNA production for therapeutic applications.

Impurity profiling and analysis of TheraPure GMP nucleotides

Impurity profiling and analysis of TheraPure GMP nucleotides

Content provided by Thermo Fisher Scientific - Biosciences | 22-Mar-2023 | White Paper

Nucleoside triphosphates (NTPs) are vital components of emerging RNA therapeutics and vaccines. Controlling impurities that may be present in them while...

Related suppliers

Follow us

Products

View more

Webinars